A Pilot Study Suggests that the G/G Genotype of Resistin Single Nucleotide Polymorphism at -420 May Be an Independent Predictor of a Reduction in Fasting Plasma Glucose and Insulin Resistance by Pioglitazone in Type 2 Diabetes
2013 ◽
Vol 13
(Suppl 1)
◽
pp. S3
◽
2008 ◽
Vol 21
(6)
◽
pp. 454-459
◽
2013 ◽
Vol 12
(4)
◽
pp. 310-315
◽